Global Health Policy Update: Tackling Antimicrobial Resistance & Investing in Pandemic Preparedness

 

View on web         CGD Update:     Global Health Policy: Tackling Antimicrobial Resistance & Investing in Pandemic Preparedness   Hi Charles, Without concerted action, it is estimated that antimicrobial resistance (AMR) will kill 10 million people globally by 2050. CGD’s global health policy team recently outlined key policy solutions to address the threat of AMR in India and Brazil. And on the sidelines of the World Health Assembly in Geneva last month, CGD experts presented two draft global recommendations to tackle AMR on both the political and operational fronts. Stay tuned for CGD’s final working group report on AMR, which will be launched at the United Nations General Assembly in September this year.   Building on CGD’s extensive commentary informing the Pandemic Fund’s establishment and operationalization, a new CGD brief looks at how the newly-created Fund can strategically invest in pandemic preparedness, including during its first call for proposals for surveillance, laboratories, and human resources.  Lastly, we take a look at CGD’s role in improving value for money of healthcare through Health Technology Assessment India (HTAIn), which has achieved a return on investment of 9:1 since its establishment in 2017.  For more on health economics, CGD is participating in several events at IHEA’s 2023 Congress next month, including a roundtable on tracking and measuring spending for pandemic preparedness and response. To register or for more details, see CGD’s website.  Please read on for more on our latest research and commentary. As always, your thoughts, feedback, and suggestions are welcome.  Sincerely,   Javier Guzman  Director, Global Health Policy Program and Senior Policy Fellow    Explore CGD’s Global Health Work         Towards the 2024 UNGA Meeting on Antimicrobial Resistance   Turning the Tide on AMR through Global Cooperation    CGD’s working group on AMR is developing two key recommendations to tackle the threat of AMR. First, a ‘Grand Bargain’ outlines principles and commitments for key stakeholders in the global antimicrobial market. Second, the establishment of a new global procurement hub for antimicrobials would support core functions, such as purchasing, distribution, and providing technical and financial assistance.    Read the blog     Tackling the Threat of AMR in India and Brazil    Every year, 300,000 and 33,000 people die of drug resistant infections in India and Brazil, respectively. CGD has partnered with the Indian School of Business and INCAE Business School to identify a number of policy options to tackle AMR. Although India and Brazil face similar challenges in terms of antimicrobial access, innovation, and stewardship, politically palatable solutions vary substantially—but if implemented, both countries have the potential to become regional leaders in the fight against AMR.   Read the blog         Investing in Surveillance for Pandemic Preparedness and Response   A new policy paper from CGD examines how analyzing the “best buys” of outbreak surveillance interventions—reflecting potential costs and benefits—can bolster pandemic preparedness efforts. Analysis suggests that the payoffs and trade-offs of investments are not easily assessed before a pandemic, highlighting the need for more rigorous, independent evaluation of the value and impact of preparedness investments (including for surveillance) after the fact to inform future pandemic response investments.    Read the blog     More on PPR   Blogs: Global Health Land Roundup: Pandemics, PEPFAR, and People – Victoria Fan, Javier Guzman The G20 Needs to Address the Lack of Coordination in the Global Vaccine Supply Chain for Pandemic Preparedness – Prashant Yadav, Tom Johnston, Ravi Anupindi The Pandemic Fund’s Results Framework: Early Reflections and Recommendations – Victoria Fan, Eleni Smitham Preparing for the Next Pandemic—and the Next Season of Pandemic Proof – Morgan Pincombe, Eleni Smitham, Amanda Glassman, Javier Guzman Podcasts: Pandemic Proof: Beginning a New Era? – Amanda Glassman, Javier Guzman Events: ​​​​​​The Other Global Challenge: Pandemic Risks and the World Bank Roadmap  Pooling for Preparedness: The Role of Procurement in Pandemic Response​​​​​​         Ending the Scourge of Lead Poisoning     1 in 3 children suffer from lead poisoning—it causes irreversible brain damage, and is linked to poor schooling outcomes, increased crime and violence, and heart and kidney damage. Yet lead pollution has been sorely neglected by the international community. A half-day event at CGD brought together experts to discuss high-impact strategies to create a future free of lead poisoning—in America and around the world.    Watch the event         Featured Policy Impact    Supporting the Institutionalization of Health Technology Assessment in India   Through the International Decision Support Initiative (iDSI), CGD has supported the use of cost-effectiveness analysis to improve the impact of health spending decisions in India. With iDSI support, HTAIn—the Indian HTA agency established in 2017—has grown into a network with 18 Regional Resource Centres across India and has achieved fundamental milestones, including formalizing processes and procedures and implementing a National Health System Cost database.  HTAIn has published more than 40 policy briefs assessing a diverse set of interventions ranging from public health initiatives (e.g., cervical cancer screening) to diagnostic tests. It has already shown its value—after assessing the benefits from three HTAs, we estimate that for every rupee spent on HTAIn to support priority setting, India has secured the equivalent of nine rupees in health system performance.   India’s continued commitment to HTA was recently reaffirmed at the second International Symposium on Health Technology Assessment organized by HTAIn, CGD, and WHO in March 2023 and attended by the Honourable Vice President of India Shri Jagdeep Dhankhar. In the words of Union Minister of Health and Family Welfare Dr Mandaviya, “HTA is an important mechanism for priority setting in the country to achieve our goal of providing equitable, better quality health care services in a cost-effective way.”  CGD will continue to support India, including through HTAIn, to promote value for money and improved health outcomes.         In Case You Missed It    Events   Why Investing in National Hospital Costing Systems Matters for Universal Healthcare – April 17 USAID Administrator Samantha Power on the Trajectory of Global Health – April 20 Debate: Do Patents Promote Health Innovation in Low- and Middle-Income Countries? – April 25 Politics and Policies in Public Health: Reflections on the Past and Challenges Moving Forward – May 5 Revamping the Regional Health Approach: A Conversation with PAHO Director Jarbas Barbosa – June 6 The Future of PEPFAR: A Conversation with Ambassador Dr. John Nkengasong on Sustainability in the HIV/AIDS Response – June 8     Research and Analysis   How WHO Can Deliver On its Core Mission of Science, Knowledge, and Evidence – Victoria Fan, Amanda Glassman, Javier Guzman  A Shot at Expanding Gavi’s Impact: Lessons Learned and Future Opportunities for Global Immunization Efforts – Morgan Pincombe, Janeen Madan Keller USAID Administrator on a Truly New USAID Health Initiative—Can it Survive? – Nancy Birdsall The Malaria Vaccination Era: How Endemic Countries and Donors Can Make the Most of R21 – Tom Drake, Javier Guzman, Peter Baker Two Key WHA Resolutions Must Learn from COVID, and Focus on Universal Scale Up of Oxygen and Essential Care – Peter Baker Universal Health Coverage Won’t Happen Tomorrow, but Here Are Some Priority-Setting Tools to Help – Jubilee Ahazie, Victoria Fan How Economists got Africa’s AIDS Epidemic Wrong – Justin Sandefur Beyond Cost-Effectiveness: Insights for Effective Altruism from Health Economics – Tom Drake         Follow Us on Twitter   Follow our experts on Twitter to keep up with the latest news and research on global health policy:  Javier Guzman, Director, Global Health Policy Program and Senior Policy Fellow – @JavierHGuzmanC  Janeen Madan Keller, Policy Fellow and Deputy Director - @JaneenMadan Peter Baker, Policy Fellow and Deputy Director – @peterbaker17  Prashant Yadav, Senior Fellow – @Prof_Yadav_SCM Rachel Silverman, Senior Fellow – @rsilv_dc  Anthony McDonnell, Senior Policy Analyst – @apmcdonnell  Srobana Ghosh, Policy Analyst – @srobanaghosh  And keep up with some of our non-resident fellows too:  Sebastian Bauhoff – @sbauhoff Ursula Giedion – @ugiedion Adriane Gheorghe – @adrianegheorghe               This email was sent to bema@blackemergmanagersassociation.org. This email was sent by: Center for Global Development 2055 L Street NW, Fifth Floor Washington, DC 20036 Tel 202.416.4000 | Fax 202.416.4050     Manage Subscriptions  |  Unsubscribe  |  About  |  Donate  |  Contact